About this trial
1. to detect the characteristic patterns of muscle involvement in suspected cases of LGMD using muscle ultrasound 2. to use the muscle ultrasound findings clinically categorized the different types of LGMD 3. to correlate the muscle ultrasound findings with the findings of the other assissed scales
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
gender : both sex are included Willingness to participate in the study and to be subjected to disease related examination and assessments Willing and able to provide informd consent
Disqualifiers
patients unable to give informed consent Patients with acute or subacute onset of symptoms of muscle involvement including inflammatory myopathies Patients with systemic diseases causing secondary myopathy
Trial population
* Patients presented with clinical manifestations suggestive of LGMD who presented with gradual progressive limb-girdle weakness ,myopathic changes on electromyography and elevated creatine phosphokinase serum level * age and sex matched healthy control group as a normal referencce
Trial design
Case-control
Prospective
Treatments tested in this trial
Muscle ultrasound
DeviceRole of muscle ultrasound in LGMD
Treatment groups
Trial outcomes
Primary outcomes
The role of muscle ultrasound in assessment of a sample of patients with limb-girdle muscular dystrophy
The role of muscle ultrasound in assessment of sample of patients with LGMD
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: